Seeking Alpha

NVAX
  Novavax, Inc. - NASDAQ

8/23/2014, 2:17 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
NVAX vs. ETF Alternatives
Company Description
Novavax, Inc. is a clinical-stage biopharmaceutical company engaged in creating differentiated, value- upon current preventive options for various infectious diseases.
Sector: Healthcare
Industry: Biotechnology
Country: United States